Safe Hearts Plan: AFNET supports integration of Health and the Safe Hearts Plan in the next EU Budget

Beiträge

NEWS

Fri., 13.11.2026

Press release

The ambition of the European Commission, expressed in the Beating Cancer plan, the Safe Hearts Plan, and similar initiatives, is to substantially improve health in the European union. In its current budget negotiations, the European Commission has the opportunity to substantiate these important ambitions. AFNET welcomes and supports this initiative of the European Union.

To underpin the ambition of the European Union in this important domain, Health needs a ring-fenced budget. AFNET therefore strongly urges all parties involved in the ongoing EU budget process to make a binding commitment to allocate the necessary funds in the next EU budget. Only a ring-fenced EU budget for Health enables the required actions to achieve the aims of the Safe Hearts Plan, the Beating Cancer Plan, and similar initiatives. This will improve the health of EU citizens, thereby increasing the competitiveness of the EU by improving the health of its workforce, and increase resilience of the EU. The Safe Hearts Plan also has the potential to reduce the current cost of treating cardiovascular diseases, estimated at more than 250 billion euros per year in the EU.

In view of the above, AFNET respectfully calls upon all stakeholders to:

  • establish a ring-fenced health strand within the European Competitiveness Fund, with a dedicated allocation of at least €10 billion, in line with the position adopted by the European Parliament.
  • establish a governance framework for EU health funding within the European Competitiveness Fund, ensuring funding decisions are guided through appropriate health expertise and aligned with the agreed aims of the EU.

About the Atrial Fibrillation NETwork (AFNET)

The Atrial Fibrillation NETwork is an interdisciplinary research network comprising scientists and physicians from hospitals and practices dedicated to improving the management of atrial fibrillation through coordinated research in Germany, Europe, and worldwide. Its main objective is to conduct high quality investigator-initiated clinical trials and registries on a national and international level as well as translational research projects. The AFNET continues the long-term activities of the network
which has been funded by the German Federal Ministry of Research and Education over a decade. Since January 2015, specific projects and infrastructures of the AFNET are funded by the German Centre for Cardiovascular Research (DZHK), and some projects by EU research grants. AFNET has long expertise in the management of atrial fibrillation, but also provides support for work in other fields informing cardiovascular care. The results of 23 years of clinical and translational research improved
the lives of patients with cardiovascular diseases and influenced treatment guidelines.

https://health.ec.europa.eu/non-communicable-diseases/cardiovascular-health_en

https://www.af-net.eu

Press Contact

Angelika Leute, PhD
Phone: +49 202 2623395
a.leute@t-online.de

Leave a Comment